Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. DexCom, Inc.
  6. News
  7. Summary
    DXCM   US2521311074

DEXCOM, INC.

(DXCM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

DexCom : Wells Fargo Upgrades DexCom to Equal-Weight From Underweight; Price Target is $380

05/28/2021 | 05:57am EDT


ę MT Newswires 2021
All news about DEXCOM, INC.
08/04INSIDER TRENDS : Dexcom Insider Continues 90-Day Selling Trend
MT
08/03DEXCOM : DXCM) sees Significant Insider Selling Continuing
MT
08/03CORRECTION : Close Update: US Stocks Retreat as Amazon Drops on Q3 Guidance; PCE..
MT
08/02INSIDER TRENDS : Dexcom Insider Continues 90-Day Selling Trend
MT
08/02DEXCOM : Morgan Stanley Adjusts DexCom's Price Target to $510 from $410, Keeps E..
MT
07/30US Stocks Retreat as Amazon Drops on Third-Quarter Guidance; PCE Inflation La..
MT
07/30CLOSE UPDATE : US Stocks Retreat as Amazon Drops on Q3 Guidance; PCE Inflation L..
MT
07/30Amazon, Pinterest fall; Charter, DexCom rise
AQ
07/30Top Midday Gainers
MT
07/30Shares Retreat Midday as Amazon Drops on Third-Quarter Guidance, PCE Inflatio..
MT
More news
Financials (USD)
Sales 2021 2 399 M - -
Net income 2021 233 M - -
Net cash 2021 564 M - -
P/E ratio 2021 219x
Yield 2021 -
Capitalization 49 780 M 49 780 M -
EV / Sales 2021 20,5x
EV / Sales 2022 16,7x
Nbr of Employees 5 500
Free-Float 98,7%
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | MarketScreener
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Last Close Price 514,53 $
Average target price 506,52 $
Spread / Average Target -1,56%
EPS Revisions
Managers and Directors
Kevin Ronald Sayer Chairman, President & Chief Executive Officer
Jereme M Sylvain SVP-Finance, Chief Financial & Accounting Officer
Andrew K. Balo EVP-Clinical Affairs, Regulatory Strategy
Jacob S. Leach Chief Technology Officer & Executive VP
Shelly R. Selvaraj Senior Vice President-Information Technology
Sector and Competitors
1st jan.Capi. (M$)
DEXCOM, INC.39.17%50 427
ABBOTT LABORATORIES11.54%216 985
MEDTRONIC PLC12.22%176 670
BECTON, DICKINSON AND COMPANY1.81%74 383
HOYA CORPORATION15.49%55 510
ALIGN TECHNOLOGY, INC.32.49%55 502